Networks of High Aspect Ratio Particles to Direct Colloidal Assembly Dynamics and Cellular Interactions
Source abstract
Abstract
Abstract Injectable colloids that self‐assemble into 3D networks are promising materials for applications in regenerative engineering, as they create open systems for cellular infiltration, interaction, and activation. However, most injectable colloids have spherical morphologies, which lack the high material‐biology contact areas afforded by higher aspect ratio materials. To address this need, injectable high aspect ratio particles (HARPs) are developed that form 3D networks to enhance scaffold assembly dynamics and cellular interactions. HARPs are functionalized for tunable surface charge through layer‐by‐layer electrostatic assembly. Positively charged chitosan‐HARPs have improved particle suspension dynamics when compared to spherical particles or negatively charged HARPs. Chit‐HARPs are used to improve the suspension dynamics and viability of MIN6 cells in 3D networks. When combined with negatively charged gelatin microsphere (GelMS) porogens, chit‐HARPs reduce GelMS sedimentation and increase overall network suspension, due to a combination of HARP network formation and electrostatic interactions. Lastly, HARPs are functionalized with fibroblast growth factor 2 (FGF2) to highlight their use for growth factor delivery. FGF2‐HARPs increase fibroblast proliferation through a combination of 3D scaffold assembly and growth factor delivery. Taken together, these studies demonstrate the development and diverse uses of high aspect ratio particles as tunable injectable scaffolds for applications in regenerative engineering.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Pickering emulsions and particle stabilization · 3D Printing in Biomedical Research · Electrospun Nanofibers in Biomedical Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Bioengineering and Therapeutic Sciences University of California, San Francisco San Francisco CA 94158 USA
Funding
UCSF HIVE
References (53)
Show source-provided references
1. 10.1038/s41578-019-0148-610.1038/s41578-019-0148-6 ↗
2. 10.1002/ijch.20130004610.1002/ijch.201300046 ↗
3. 10.1038/nmat375810.1038/nmat3758 ↗
4. 10.1038/nmat502010.1038/nmat5020 ↗
5. 10.1002/adhm.20170106510.1002/adhm.201701065 ↗
6. 10.1002/biot.20160039410.1002/biot.201600394 ↗
7. 10.1016/j.addr.2017.11.00510.1016/j.addr.2017.11.005 ↗
8. 10.1002/btm2.1014710.1002/btm2.10147 ↗
9. 10.1038/nmat447410.1038/nmat4474 ↗
10. 10.1038/s41551-019-0442-z10.1038/s41551-019-0442-z ↗
11. 10.1002/adfm.20190767010.1002/adfm.201907670 ↗
12. 10.1038/nmat429410.1038/nmat4294 ↗
13. 10.1016/j.biomaterials.2013.02.05110.1016/j.biomaterials.2013.02.051 ↗
14. 10.1016/j.actbio.2005.04.00210.1016/j.actbio.2005.04.002 ↗
15. 10.1021/acsnano.5b0067910.1021/acsnano.5b00679 ↗
16. 10.1021/acsnano.7b0123910.1021/acsnano.7b01239 ↗
17. 10.1002/adma.20070209910.1002/adma.200702099 ↗
18. 10.1016/j.cocis.2013.07.00410.1016/j.cocis.2013.07.004 ↗
19. 10.1039/c3sm50404b10.1039/c3sm50404b ↗
20. 10.1016/j.copbio.2018.11.00110.1016/j.copbio.2018.11.001 ↗
21. 10.1016/j.addr.2019.01.00210.1016/j.addr.2019.01.002 ↗
22. Finbloom J. A. · Adv. Drug Delivery Rev. · 2020
23. 10.1016/j.biomaterials.2019.11945810.1016/j.biomaterials.2019.119458 ↗
24. 10.1089/ten.tea.2011.060610.1089/ten.tea.2011.0606 ↗
25. 10.1016/j.addr.2018.02.00210.1016/j.addr.2018.02.002 ↗
26. 10.1039/c3tb20795a10.1039/c3tb20795a ↗
27. 10.1021/acs.nanolett.7b0292910.1021/acs.nanolett.7b02929 ↗
28. 10.1002/adhm.20140064110.1002/adhm.201400641 ↗
29. 10.1021/acs.chemrev.7b0019410.1021/acs.chemrev.7b00194 ↗
30. 10.1038/nnano.2007.7010.1038/nnano.2007.70 ↗
31. 10.3390/nano812100710.3390/nano8121007 ↗
32. 10.1016/j.biomaterials.2014.07.00510.1016/j.biomaterials.2014.07.005 ↗
33. 10.1016/j.biomaterials.2018.03.04210.1016/j.biomaterials.2018.03.042 ↗
34. 10.1021/acsnano.7b0609410.1021/acsnano.7b06094 ↗
35. 10.1016/j.biomaterials.2019.11962610.1016/j.biomaterials.2019.119626 ↗
36. Hernández A. R. · Am. J. Polym. Sci. · 2013 · 3 · 70
37. 10.1002/pi.209010.1002/pi.2090 ↗
38. 10.1016/j.jconrel.2016.01.04010.1016/j.jconrel.2016.01.040 ↗
39. 10.1586/eri.11.5910.1586/eri.11.59 ↗
40. 10.1039/C4CC04317K10.1039/C4CC04317K ↗
41. 10.1016/j.carbpol.2018.07.06210.1016/j.carbpol.2018.07.062 ↗
42. 10.3184/095422910X1269270125529710.3184/095422910X12692701255297 ↗
43. 10.1260/0263-6174.32.7.55710.1260/0263-6174.32.7.557 ↗
44. 10.1021/acsnano.5b0067910.1021/acsnano.5b00679 ↗
45. 10.1021/acsbiomaterials.9b0033210.1021/acsbiomaterials.9b00332 ↗
46. 10.1021/acsabm.9b0009210.1021/acsabm.9b00092 ↗
47. 10.1002/btm2.1012410.1002/btm2.10124 ↗
48. 10.1016/j.actbio.2014.11.02810.1016/j.actbio.2014.11.028 ↗
49. Demaree B. · J. Visualized Exp. · 2018 · 2018 · 57598
50. 10.1038/s41598-019-46408-010.1038/s41598-019-46408-0 ↗
51. 10.1002/bit.2653110.1002/bit.26531 ↗
52. 10.1038/nrd279210.1038/nrd2792 ↗
53. 10.1021/acsnano.9b0079210.1021/acsnano.9b00792 ↗